103 related articles for article (PubMed ID: 19793253)
1. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
Ueno K; Nomura Y; Hashiguchi T; Masuda K; Morita Y; Hazeki D; Eguchi T; Maruyama I; Kawano Y
Br J Haematol; 2010 Jan; 148(2):285-92. PubMed ID: 19793253
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of vascular leakage in acute Kawasaki disease.
Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
[TBL] [Abstract][Full Text] [Related]
5. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
[TBL] [Abstract][Full Text] [Related]
6. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
[TBL] [Abstract][Full Text] [Related]
8. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
[TBL] [Abstract][Full Text] [Related]
10. Predicting IVIG resistance in UK Kawasaki disease.
Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
[TBL] [Abstract][Full Text] [Related]
11. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
[TBL] [Abstract][Full Text] [Related]
12. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Ueno K; Nomura Y; Morita Y; Eguchi T; Masuda K; Kawano Y
Circ J; 2015; 79(6):1349-56. PubMed ID: 25787672
[TBL] [Abstract][Full Text] [Related]
13. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
14. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
15. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
[TBL] [Abstract][Full Text] [Related]
16. Platelet: transporter of vascular endothelial growth factor.
Verheul HM; Hoekman K; Luykx-de Bakker S; Eekman CA; Folman CC; Broxterman HJ; Pinedo HM
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2187-90. PubMed ID: 9815613
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003.
Belay ED; Maddox RA; Holman RC; Curns AT; Ballah K; Schonberger LB
Pediatr Infect Dis J; 2006 Mar; 25(3):245-9. PubMed ID: 16511388
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
20. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]